Metrics as of 10/13/2026, 06:39 PM (Berlin time), refresh in progress.
Nexalin Technology Stock
Nexalin Technology, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Mark White
- Employees
- 8
- Market cap
- $2 M
- IPO
- 16/09/2022
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free…
Nexalin Technology stock: price history
1D
-21.4%
1W
-41.3%
1M
-45.2%
6M
-79.5%
YTD
-84.2%
1Y
-93.4%
2Y
-88.7%
5Y
–
10Y
–
Next earnings date
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~6% stronger price swings than usual
Ask the agents about Nexalin Technology
Analyst assessment of Nexalin Technology
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 24/03/2025
Nexalin Technology stock metrics
P/E
-0.18
P/B
1.22
EV/EBITDA
-0.1
RETURN ON EQUITY
-147.4%
NET MARGIN
-18,412.7%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
80.9%
FLOAT SHARES
593,608
AVG. DAILY VOLUME (30D)
2,175,210
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Nexalin Technology stock
What does Nexalin Technology do?
Nexalin Technology, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Mark White, the company employs around 8 people.
The IPO was on 16/09/2022; the stock trades on NASDAQ under the ticker NXL.
What do analysts say about Nexalin Technology stock?
1 analysts rate the stock, the consensus is Buy (as of 24/03/2025).
This is an external assessment, not a statement by Market Jury.
When does Nexalin Technology report next?
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly 6% stronger than usual.
Does Nexalin Technology pay a dividend?
No, Nexalin Technology currently does not pay a dividend.
Which stocks are comparable to Nexalin Technology?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Nexalin Technology stock analyzed?
Clicking "Analyze stock" lets five strategies assess Nexalin Technology against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.